What makes Mounjaro different?
While Ozempic targets the GLP-1 hormone, Mounjaro (Tirzepatide) is a dual agonist that also targets the GIP (glucose-dependent insulinotropic polypeptide) hormone.
Superior Weight Loss
Clinical trials show Mounjaro can lead to significantly higher weight loss compared to single-hormone treatments.
Blood Sugar Control
Excellent for improving metabolic health and managing insulin sensitivity.
Is Mounjaro right for you?
Our licensed doctors will assess your BMI and medical history to see if Tirzepatide is the best option for your goals.